FDA approves belimumab for treatment of children with lupus nephritis

Pediatric pharmacology
Pediatričeskaâ farmakologiâ

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

eng | рус

Pediatric pharmacology

Advanced search

FDA approves belimumab for treatment of children with lupus nephritis. Pediatric pharmacology. 2022;19(4):354. (In Russ.)

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?